다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
동서간호학연구지 = Journal of East-West nursing research, v.22 no.2, 2016년, pp.148 - 157
강경옥 (전북대학교 일반대학원 간호학과) , 김현경 (전북대학교 간호대학.간호과학연구소) , 김지영 (전북대학교 간호대학.간호과학연구소) , 임석태 (전북대학교 의학전문대학원 핵의학과)
AI-Helper
Purpose: The purpose of this study was to explore the meaning of the experience of receiving radioactive iodine therapy among patients with thyroid cancer. Methods: A qualitative research design was adopted. The participants were ten women diagnosed with thyroid cancer who had received radioactive i...
| 핵심어 | 질문 | 논문에서 추출한 답변 |
|---|---|---|
| 갑상선암이 급증하는 이유는? | 5%를차지하였다[1]. 갑상선암이 급증하고 있는 원인으로는 과거에 비해 갑상선의 조기검진과 진단 시스템이 발달되면서 갑상선암의 조기발견이 훨씬 용이해졌다는점과다른암에비해갑상선암발생에환경적인소인보다유전적인 소인이 더 큰 비중을 차지하고 있으며, 특히 우리나라 사람들의 갑상선암에 대한 이환율이 높다는 점 등이 제시되고 있다[2]. 발생률이 높은 반면 갑상선암의 치료 결과와 예후는 매우 좋아 10년암 상대생존율(10-year cancer relative survival rate)은 99. | |
| 갑상선암 일반적 치료방향은 무엇인가? | 갑상선암의 일반적인 치료방향은 갑상선절제술 후 재발을 막기 위해 방사성요오드 치료를 시행하는 것이다[3]. 요오드는 갑상선호르몬의 전구물질로서 방사성요오드가 들어있는 캡슐을 복용하게 되면 위장관을 통해 흡수되어 정상 갑상선조직이나 갑상선암조직에 선택적으로 흡수된 뒤 고농도로 농축되고 방사선을 방출하여 조직을 파괴함으로써 암재발의 위험성을 낮추게된다[4]. | |
| 방사성요오드 치료 과정은? | 갑상선암의 일반적인 치료방향은 갑상선절제술 후 재발을 막기 위해 방사성요오드 치료를 시행하는 것이다[3]. 요오드는 갑상선호르몬의 전구물질로서 방사성요오드가 들어있는 캡슐을 복용하게 되면 위장관을 통해 흡수되어 정상 갑상선조직이나 갑상선암조직에 선택적으로 흡수된 뒤 고농도로 농축되고 방사선을 방출하여 조직을 파괴함으로써 암재발의 위험성을 낮추게된다[4]. |
National Cancer Center. Annual report of cancer statistics in Korea in 2013. Goyang: National Cancer Center; 2015 [cited 2016 May 5]. Available from: http://www.ncc.re.kr/cancerStatsView.ncc?bbsnum358&searchKeytotal&searchValue&pageNum1
Chung JH. A refutation against unfounded reports on thyroid cancer. Journal of Korean Thyroid Association. 2014;7(1):1-6. http://dx.doi.org/10.11106/jkta.2014.7.1.1
Yi KH, Park YJ, Koong SS, Kim JH, Na DG, Ryu JS, et al. Revised Korean thyroid association management guidelines for patients with thyroid nodules and thyroid cancer. Endocrinology and Metabolism. 2010;25(4):270-297. https://doi.org/10.3803/EnM.2010.25.4.270
Kim WB, Seok JW, Kim MH, Kim BI, Park YJ, Lee KE, et al. Korean thyroid association guidelines for patients undergoing radioiodine therapy for differentiated thyroid cancers (First Edition, 2012). Journal of Korean Thyroid Association. 2013;6(1):12-25. http://dx.doi.org/10.11106/jkta.2013.6.1.12
Bae SK. Recent advances in radioiodine therapy for thyroid cancer. Nuclear Medicine and Molecular Imaging. 2006;40(2):132-140.
Kim YS. Effects of the information providing program of $I^{131}$ treatment on the anxiety and immune response of patients with thyroid cancer. Asian Oncology Nursing. 2006;6(2): 152-161.
Stajduhar KI, Neithercut J, Chu E, Pham P, Rohde J, Sicotte A, et al. Thyroid cancer: patients' experiences of receiving iodine-131 therapy. Oncology Nursing Forum, 2000;27(8):1213-1218.
Kang SM, Kim BI, Kim IJ, Bom HS, Lee GH, Lee JT, et al. Radiation safety in the treatment of patients with thyroid disease by 131I. Journal of Korean Thyroid Association. 2012;5(1):6-14. http://dx.doi.org/10.11106/jkta.2012.5.1.6
Roerink SH, de Ridder M, Prins J, Huijbers A, de Wilt HJ, Marres H, et al. High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer. Acta Oncologica. 2013;52:128-137. http://dx.doi.org/10.3109/0284186x.2012.723822
Huang SM, Lee CH, Chien LY, Liu HE, Tai CJ. Postoperative quality of life among patients with thyroid cancer. Journal of Advanced Nursing. 2004;47(5):492-499. http://dx.doi.org/10.1111/j.1365-2648.2004.03128.x
Lee JI, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, et al. Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health and Quality of Life Outcomes. 2010;8:101. http://dx.doi.org/10.1186/1477-7525-8-101
Yang JY, Yi MS. Factors influencing quality of life in thyroid cancer patients with thyroidectomy. Asian Oncology Nursing. 2015;15(2):59-66. http://dx.doi.org/10.5388/aon.2015.15.2.59
Mendoza A, Shaffer B, Karakla, D, Mason ME, Elkins D, Goffman TE. Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction. Thyroid. 2004;14(2):133-140. http://dx.doi.org/10.1089/105072504322880373
Creswell JW. Qualitative inquiry & research design: choosing among five approaches. 3rd ed. Cho HS, Jeong SW, Kim JS, Kwon JS, translator. Seoul: Hakjisa Publisher; 2016. p.63-70.
Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, et al. The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One. 2009;4(1):e4191. http://dx.doi.org/10.1371/journal.pone.0004191
Easley J, Miedema B, Robinson L. It's the "good" cancer, so who cares? Perceived lack of support among young thyroid cancer survivors. Oncology Nursing Forum. 2013;40(6):596-600. http://dx.doi.org/10.1188/13.onf.596-600
Misra S, Meiyappan S, Freeman J, Rotstein L, Brierley JD, Tsang RW, et al. Patients' experiences following local-regional recurrence of thyroid cancer: a qualitative study. Journal of Surgical Oncology. 2013;108(1):47-51. http://dx.doi.org/10.1002/jso.23345
Lee N. Phenomenology and qualitative research. Seoul: Hangilsa Publishing Co.; 2014. p.38-45.
Colaizzi PF. Psychological research as the phenomenologist views it. In: Valle RS, King M, editors. Existential-phenomenological alternatives for psychology. New York, NY: Oxford University Press Inc.; 1978. p.48-71.
Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Thousand Oaks, CA: Sage; 1994. p. 105-117.
Taieb D, Sebag F, Cherenko M, Baumstarck-Barrau K, Fortanier C, Farman-Ara B, et al. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study. Clinical Endocrinology. 2009;71(1):115-123. http://dx.doi.org/10.1111/j.1365-2265.2008.03424.x
Kwak KH. Stress and quality of life related to the disease of women with thyroid cancer. [master's thesis]. Seoul: Catholic University; 2009.
van Nostrand D. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer. Thyroid. 2009;19(12):1381-1391. http://dx.doi.org/10.1089/thy.2009.1611
Park EY, Yi MS. Illness experience of women with breast cancer in Korea: using feminist penomenology. Korean Journal of Adult Nursing. 2009;21(5):504-518.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.